bpc 157 tumor growth BPC-157, TB-500, and GHK-Cu: Separating Fact from Fear in Cancer Concerns | Gabriel Alizaidy, MD, MS posted on the topic BPC-157 is being marketed as
Description
This compound is supplied in lyophilized (freeze-dried) powder form to support stability and consistency in controlled laboratory research applications
The jury is still out
Vortexing creates an air-water interface and shear forces that denature peptides via foam and cavitation, and partially dissociates Cu(II) from the GHK chelate
Its all about making therapy fit each patients needs and the reason for their deficiency
Want 2.5 mg
